• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of canfamphysLink to Publisher's site
Can Fam Physician. Jan 2001; 47: 79–86.
PMCID: PMC2014701

Vitamin B12 injections versus oral supplements. How much money could be saved by switching from injections to pills?

Abstract

OBJECTIVE: To estimate savings, using a third-party payer perspective, if all elderly patients currently receiving vitamin B12 (cobalamin) injections were switched to high-dose oral therapy. DESIGN: We modeled high-dose oral B12 supplement costs to include drugs, pharmacists' fees, and one-time conversion costs consisting of two physician visits and laboratory monitoring. The number of vitamin-injection visits avoided by switching to oral therapy was predicted using a multivariate model that considered covariates for overall patient illness. SETTING: Ontario family physicians' and internists' practices. PARTICIPANTS: Population-based administrative databases for Ontario were used to identify all people between 65 and 100 years who received parenteral vitamin B12 during 1995 and 1996. MAIN OUTCOME MEASURES: The cost of parenteral vitamin B12 for each patient, including drugs, injections, pharmacists' fees, and injection-associated physician visits, was measured directly from the databases. RESULTS: The annual cost of parenteral vitamin B12 therapy averaged $145.88 per person and totaled a maximum $25 million over 5 years. Converting all patients to high-dose oral B12 and treating them for 5 years would cost $7.4 million. Depending on how many vitamin-injection visits are avoided by switching to oral therapy, between $2.9 million and $17.6 million would be saved. Switching to oral B12 administration saved costs as long as 16.3% of injection-associated visits were avoided. CONCLUSION: Switching all patients from B12 injections to oral cobalamin therapy could result in substantial savings.

Full Text

The Full Text of this article is available as a PDF (62K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Lederle FA. Oral cobalamin for pernicious anemia. Medicine's best kept secret? JAMA. 1991 Jan 2;265(1):94–95. [PubMed]
  • Berlin H, Berlin R, Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med Scand. 1968 Oct;184(4):247–258. [PubMed]
  • WAIFE SO, JANSEN CJ, Jr, CRABTREE RE, GRINNAN EL, FOUTS PJ. Oral vitamin B12 without intrinsic factor in the treatment of pernicious anemia. Ann Intern Med. 1963 May;58:810–817. [PubMed]
  • Berlin R, Berlin H, Brante G, Pilbrant A. Vitamin B12 body stores during oral and parenteral treatment of pernicious anaemia. Acta Med Scand. 1978;204(1-2):81–84. [PubMed]
  • Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood. 1998 Aug 15;92(4):1191–1198. [PubMed]
  • Lederle FA. Cyanocobalamin--a case for withdrawal. J R Soc Med. 1993 May;86(5):308–309. [PMC free article] [PubMed]
  • Stabler SP, Lindenbaum J, Allen RH. Vitamin B-12 deficiency in the elderly: current dilemmas. Am J Clin Nutr. 1997 Oct;66(4):741–749. [PubMed]
  • Pruthi RK, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc. 1994 Feb;69(2):144–150. [PubMed]
  • Watts DT. Vitamin B12 replacement therapy: how much is enough? Wis Med J. 1994 May;93(5):203–205. [PubMed]
  • Markle HV. Cobalamin. Crit Rev Clin Lab Sci. 1996;33(4):247–356. [PubMed]
  • Delva MD. Vitamin B12 replacement. To B12 or not to B12? Can Fam Physician. 1997 May;43:917–922. [PMC free article] [PubMed]
  • Elia M. Oral or parenteral therapy for B12 deficiency. Lancet. 1998 Nov 28;352(9142):1721–1722. [PubMed]
  • Verhaeverbeke I, Mets T, Mulkens K, Vandewoude M. Normalization of low vitamin B12 serum levels in older people by oral treatment. J Am Geriatr Soc. 1997 Jan;45(1):124–125. [PubMed]
  • Altay C, Cetin M. Oral treatment in selective vitamin B12 malabsorption. J Pediatr Hematol Oncol. 1997 May-Jun;19(3):245–246. [PubMed]
  • Lederle FA. Oral cobalamin for pernicious anemia: back from the verge of extinction. J Am Geriatr Soc. 1998 Sep;46(9):1125–1127. [PubMed]
  • Berlin R. Vitamin B 12 injections. Br Med J (Clin Res Ed) 1985 Jul 6;291(6487):56–56. [PMC free article] [PubMed]
  • Middleton J, Wells W. Vitamin B12 injections: considerable source of work for the district nurse. Br Med J (Clin Res Ed) 1985 Apr 27;290(6477):1254–1255. [PMC free article] [PubMed]
  • Hathcock JN, Troendle GJ. Oral cobalamin for treatment of pernicious anemia? JAMA. 1991 Jan 2;265(1):96–97. [PubMed]
  • Sonnenberg FA, Roberts MS, Tsevat J, Wong JB, Barry M, Kent DL. Toward a peer review process for medical decision analysis models. Med Care. 1994 Jul;32(7 Suppl):JS52–JS64. [PubMed]
  • Naglie G, Tansey C, Krahn MD, O'Rourke K, Detsky AS, Bolley H. Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65. CMAJ. 1999 Mar 23;160(6):805–811. [PMC free article] [PubMed]
  • Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992 Feb 15;146(4):473–481. [PMC free article] [PubMed]
  • Savage D, Lindenbaum J. Relapses after interruption of cyanocobalamin therapy in patients with pernicious anemia. Am J Med. 1983 May;74(5):765–772. [PubMed]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...